AI assistant
VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2012
Jul 26, 2012
29864_dirs_2012-07-26_116f5b97-112c-4444-8a0e-82b1d94080b6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2012-07-25
Reporting Person: Pace Megan E (SVP, Corp. Communications)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 9749 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $37.29 | 2020-05-09 | Common Stock (30000) | Direct | |
| Employee Stock Option (right to buy) | $38.80 | 2021-02-02 | Common Stock (18750) | Direct | |
| Employee Stock Option (right to buy) | $51.75 | 2021-07-12 | Common Stock (7500) | Direct | |
| Employee Stock Option (right to buy) | $37.86 | 2022-02-01 | Common Stock (11250) | Direct |
Footnotes
F1: Includes (a) 2,000 shares of common stock vesting in two equal installments on 5/1/2013 and 5/1/2014; (b) 1,250 shares of common stock vesting on 2/3/2015, subject to acceleration upon achievement of Company performance goals; and (c) 2,500 shares of common stock vesting on 2/2/2016, subject to acceleration upon achievement of Company performance goals.
F2: Right to buy under 2006 Stock and Option Plan vesting in 16 quarterly installments from 5/10/2010.
F3: Right to buy under 2006 Stock and Option Plan vesting in 16 quarterly installments from 2/3/2011.
F4: Right to buy under 2006 Stock and Option Plan vesting in 16 quarterly installments from 7/13/2011.
F5: Right to buy under 2006 Stock and Option Plan vesting in 16 quarterly installments from 2/2/2012.